Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1969 1
1970 1
1972 1
1973 12
1974 21
1975 47
1976 29
1977 27
1978 16
1979 12
1980 18
1981 12
1982 23
1983 15
1984 20
1985 20
1986 25
1987 21
1988 20
1989 25
1990 20
1991 17
1992 30
1993 45
1994 33
1995 47
1996 47
1997 45
1998 72
1999 66
2000 56
2001 48
2002 51
2003 52
2004 23
2005 33
2006 32
2007 37
2008 15
2009 24
2010 26
2011 20
2012 21
2013 15
2014 18
2015 20
2016 8
2017 19
2018 11
2019 7
2020 4
2021 9
2022 5
2023 4
2024 6
2025 8
2026 4

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,321 results

Results by year

Filters applied: . Clear all
Page 1
Single inhaler extrafine triple therapy in uncontrolled asthma (TRIMARAN and TRIGGER): two double-blind, parallel-group, randomised, controlled phase 3 trials.
Virchow JC, Kuna P, Paggiaro P, Papi A, Singh D, Corre S, Zuccaro F, Vele A, Kots M, Georges G, Petruzzelli S, Canonica GW. Virchow JC, et al. Lancet. 2019 Nov 9;394(10210):1737-1749. doi: 10.1016/S0140-6736(19)32215-9. Epub 2019 Sep 30. Lancet. 2019. PMID: 31582314 Clinical Trial.
Here we report on two studies that compared the single-inhaler extrafine combination of beclometasone dipropionate (BDP; inhaled corticosteroid), formoterol fumarate (FF; long-acting beta(2) agonist), and glycopyrronium (G; long-acting muscarinic antagonist) with the combi …
Here we report on two studies that compared the single-inhaler extrafine combination of beclometasone dipropionate (BDP; inhaled cort …
Comparison of anti-inflammatory and clinical effects of beclomethasone dipropionate and salmeterol in moderate asthma.
Bacci E, Di Franco A, Bartoli ML, Carnevali S, Cianchetti S, Dente FL, Giannini D, Vagaggini B, Ruocco L, Paggiaro PL. Bacci E, et al. Eur Respir J. 2002 Jul;20(1):66-72. doi: 10.1183/09031936.02.00094202. Eur Respir J. 2002. PMID: 12166584 Free article. Clinical Trial.
After 2 and 4 weeks of beclomethasone treatment, both serum ECP and EPX decreased. With salmeterol, only serum EPX decreased, after 4 weeks. Bronchial hyperresponsiveness to methacholine did not change after either treatment. The authors conclude that beclomethasone …
After 2 and 4 weeks of beclomethasone treatment, both serum ECP and EPX decreased. With salmeterol, only serum EPX decreased, after 4 …
[Efficacy and safety of inhaled salbutamol sulfate combined with beclomethasone dipropionate in children with bronchial asthma: a randomized controlled study].
Chen CZ, Yang Q. Chen CZ, et al. Zhongguo Dang Dai Er Ke Za Zhi. 2025 Nov 15;27(11):1373-1377. doi: 10.7499/j.issn.1008-8830.2503070. Zhongguo Dang Dai Er Ke Za Zhi. 2025. PMID: 41250537 Free PMC article. Clinical Trial. Chinese.
OBJECTIVES: To investigate the efficacy and safety of inhaled salbutamol sulfate combined with beclomethasone dipropionate in the treatment of pediatric bronchial asthma. METHODS: A total of 106 children with bronchial asthma treated from December 2022 to November 2023 wer …
OBJECTIVES: To investigate the efficacy and safety of inhaled salbutamol sulfate combined with beclomethasone dipropionate in the tre …
A comparative trial of flunisolide and beclomethasone dipropionate in the treatment of perennial allergic rhinitis.
Sahay JN, Chatterjee SS, Engler C. Sahay JN, et al. Clin Allergy. 1980 Jan;10(1):65-70. doi: 10.1111/j.1365-2222.1980.tb02081.x. Clin Allergy. 1980. PMID: 6988106 Clinical Trial.
An open, parallel comparison of flunisolide and beclomethasone dipropionate nasal sprays is described. Sixty patients entered the study of whom fifty-six completed the full 4 weeks' therapy. The dosage of flunisolide was two actuations (25 micrograms/actuation) into each n …
An open, parallel comparison of flunisolide and beclomethasone dipropionate nasal sprays is described. Sixty patients entered the stu …
Double-blind cross-over trial comparing intranasal beclomethasone dipropionate and placebo in perennial rhinitis.
Gibson GJ, Maberly DJ, Lal S, Ali MM, Butler AG. Gibson GJ, et al. Br Med J. 1974 Nov 30;4(5943):503-4. doi: 10.1136/bmj.4.5943.503. Br Med J. 1974. PMID: 4140005 Free PMC article. Clinical Trial.
Twenty-five patients with perennial rhinitis completed a double-blind cross-over trial of intranasal beclomethasone dipropionate 200 mug daily and placebo. Of these patients 19 preferred the active drug and two preferred placebo. ...
Twenty-five patients with perennial rhinitis completed a double-blind cross-over trial of intranasal beclomethasone dipropionate 200 …
Beclomethasone inhaler versus intravenous lidocaine in the prevention of postoperative airway and throat complaints: a randomized, controlled trial.
Honarmand A, Safavi M. Honarmand A, et al. Ann Saudi Med. 2008 Jan-Feb;28(1):11-6. doi: 10.5144/0256-4947.2008.11. Ann Saudi Med. 2008. PMID: 18299653 Free PMC article. Clinical Trial.
BACKGROUND AND OBJECTIVE: Previous reports indicate that inhaled corticosteroids attenuate airway inflammation. Beclomethasone inhaler was highly effective in the prevention of postoperative airway symptoms. ...In addition, beclomethasone inhaler decreases the incid …
BACKGROUND AND OBJECTIVE: Previous reports indicate that inhaled corticosteroids attenuate airway inflammation. Beclomethasone inhale …
Adrenal function and high dose inhaled corticosteroids for asthma.
Yiallouros PK, Milner AD, Conway E, Honour JW. Yiallouros PK, et al. Arch Dis Child. 1997 May;76(5):405-10. doi: 10.1136/adc.76.5.405. Arch Dis Child. 1997. PMID: 9196354 Free PMC article. Clinical Trial.
OBJECTIVE: To investigate effects on adrenal function of fluticasone, a recently released inhaled steroid preparation with lower systemic bioavailability than beclomethasone dipropionate. METHODS: 34 children on high doses (400-909 micrograms/m2/d) of inhaled beclometha …
OBJECTIVE: To investigate effects on adrenal function of fluticasone, a recently released inhaled steroid preparation with lower systemic bi …
Beclomethasone dipropionate: II: Allergic rhinitis and other conditions.
Brogden RN, Pinder RM, Sawyer PR, Speight TM, Avery GS. Brogden RN, et al. Drugs. 1975;10(3):211-7. doi: 10.2165/00003495-197510030-00003. Drugs. 1975. PMID: 811455 Review.
At doses similar to those used in the treatment of chronic bronchial asthma, intranasal beclomethasone dipropionate is effective in alleviating nasal symptoms of seasonal allergic and perennial rhinitis in about three-quarters of patients. ...The carry-over effect of the e …
At doses similar to those used in the treatment of chronic bronchial asthma, intranasal beclomethasone dipropionate is effective in a …
Infections after endoscopic polypectomy using nasal steroids.
Bross-Soriano D, Arrieta-Gómez JR, Prado-Calleros H. Bross-Soriano D, et al. Otolaryngol Head Neck Surg. 2004 Mar;130(3):319-22. doi: 10.1016/j.otohns.2003.09.021. Otolaryngol Head Neck Surg. 2004. PMID: 15054373 Clinical Trial.
BACKGROUND: Topical nasal steroids such as beclomethasone dipropionate and fluticasone propionate have been widely used in the treatment of rhinitis and polyposis. ...RESULTS: Three patients, 2 in the placebo group and 1 in the beclomethasone group, developed infect …
BACKGROUND: Topical nasal steroids such as beclomethasone dipropionate and fluticasone propionate have been widely used in the treatm …
Effects of inhaled beclometasone dipropionate/formoterol fumarate/glycopyrronium vs. beclometasone dipropionate/formoterol fumarate and placebo on lung hyperinflation and exercise endurance in chronic obstructive pulmonary disease: a randomised controlled trial.
Watz H, Kirsten AM, Ludwig-Sengpiel A, Krüll M, Mroz RM, Georges G, Varoli G, Charretier R, Cortellini M, Vele A, Galkin D. Watz H, et al. Respir Res. 2024 Oct 17;25(1):378. doi: 10.1186/s12931-024-02993-x. Respir Res. 2024. PMID: 39420338 Free PMC article. Clinical Trial.
BACKGROUND: The single-inhaler triple combination of beclometasone dipropionate, formoterol fumarate, and glycopyrronium (BDP/FF/G) is available for maintenance therapy of chronic obstructive pulmonary disease (COPD). ...
BACKGROUND: The single-inhaler triple combination of beclometasone dipropionate, formoterol fumarate, and glycopyrronium (BDP/FF/G) i …
1,321 results